Responses
Clinical and epidemiological research
Extended report
Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?
Compose a Response to This Article
Other responses
No responses have been published for this article.